Vasculitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You do not object to taking part in the study
- You are using a reliable form of contraception
- You have been diagnosed with Behçet's disease according to the internationally recognised criteria (updated in 2013)
- Your doctor has recommended ustekinumab or apremilast as part of your standard treatment for Behçet's syndrome affecting your skin and mucous membranes
- If being considered for the ustekinumab group: You have active, recurring symptoms affecting your skin or mucous membranes (such as mouth ulcers, genital ulcers, skin lesions, or joint pain/inflammation) that have not responded to, or you could not tolerate, colchicine or apremilast
- If being considered for the apremilast group: You have recurring active skin or mucous membrane symptoms from Behçet's syndrome and have not yet received any treatment for them
- For mouth ulcers specifically: you have had two or more mouth ulcers in the month before joining the trial, and this has happened at least three times in the past 12 months, even after trying colchicine
Who may not be able to join:
- You are currently pregnant
- You have previously tried ustekinumab and it did not work for you
- You have an active long-term infection (such as active tuberculosis, hepatitis B, or HIV) or an active cancer
- You have received a live vaccine in the past 3 months
- Your kidneys are not working well enough (confirm with trial site)
- Your liver is not working well enough, based on blood test results (confirm with trial site)
- Your blood counts are too low — this includes low platelets, low white blood cells, or low red blood cells/haemoglobin (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33142178042
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Success at Week 24 will be defined as the absence of active mucocutaneous manifestations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.